Armen Aprikian
McGill University Health Centre
283 Papers
2.2K Citations
Armen Aprikian is an academic researcher from McGill University Health Centre. The author has contributed to research in topics: Prostate cancer & Medicine. The author has an hindex of 48, co-authored 243 publications. Previous affiliations of Armen Aprikian include National Institutes of Health & Memorial Sloan Kettering Cancer Center.
Chat about Author
Papers
Robotic-assisted radical nephrectomy for renal angiomyolipoma with inferior vena cava thrombus extension.
TL;DR: A case of a 35-year-old lady with angiomyolipoma with inferior vena caval thrombus that was managed surgically with robotic-assisted radical nephrectomy is reported.
3
Sclerosing epithelioid fibrosarcoma metastasizing to the penile shaft.
TL;DR: This is the first documented metastasis of SEF to the penis, and these sarcomas have proven difficult to treat, with high recurrence rates despite a multimodal approach.
UPDATE - Canadian Urological Association guideline on androgen deprivation therapy: Adverse events and management strategies Summary of changes.
Andrea Kokorovic,Alan So,Hosam Serag,Christopher French,B. Hamilton,Jason P. Izard,Jasmir G. Nayak,Frédéric Pouliot,Fred Saad,Bobby Shayegan,Armen Aprikian,Ricardo A. Rendon +11 more
TL;DR: The purpose of this guideline is to summarize the major adverse events associated with conventional ADT and provide evidence-based strategies to mitigate them.
3
•Journal Article
Analysis of gland volume effect on the performance of PSA density in early detection of non-palpable, isoechoic prostate cancer.
Pierre I. Karakiewicz,Michel Bazinet,Armen Aprikian,Claude Trudel,Samual Aronson,François Péloquin,Jean Dessureault,Mahmoud Nachabe,Michelle S. Goyal,Louis R. Bégin,Mostafa M. Elhilali +10 more
TL;DR: Although PSAD may represent a useful adjunct in the early detection of prostate cancer, it may compromise cancer detection in a substantial proportion of cases, if used as the only indicator for biopsy.
2
PSA for prostate cancer detection: In serum, in urine or both?
TL;DR: Urologists who are looking for ways to reduce unnecessary prostatic biopsies, urinary PSA may one day be added to the series of biomarkers and nomograms for such a purpose, however, for those who do not wish to miss any prostate cancers, urine PSA will probably not be very useful.